FindTrial
Sign In

Research on Artificial Intelligence Assisted Accurate Treatment and Management Strategy of Severe Inflammatory Bowel Disease

Research on Artificial Intelligence Assisted Accurate Treatment and Management Strategy of Severe Inflammatory Bowel Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048588
Enrollment
Unknown
Registered
2021-07-11
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

case series:Artificial Intelligence Assisted Accurate Treatment and Management Strategy of Severe Inflammatory Bowel Disease

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as IBD according to the diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Those who are seriously ill and unable to cooperate; 2. Patients or their family members do not agree.

Design outcomes

Primary

MeasureTime frame
Inflammatory biomarkers;Activity score;nutriture;muscle content;serum markers;Molecular genetic index;—

Countries

China

Contacts

Public ContactYang Xiaoyun

Qilu Hospital of Shandong University

yangxiaoyun@sdu.edu.cn+86 18560080281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026